Medicago has started recruiting participants for the Phase 3 trial of its COVID-19 vaccine candidate. (Medicago)

Medicago has started recruiting participants for the Phase 3 trial of its COVID-19 vaccine candidate. (Medicago)

Canadian company starts Phase 3 of plant-derived COVID-19 vaccine clinical trials

Feds have agreement to buy up to 76 million doses of the vaccine if it is approved

A Quebec-based biopharmaceutical company is beginning to recruit participants for its Phase 3 trial of a plant-derived COVID-19 vaccine.

In a Tuesday (March 16) news release, Medicago said that it had received approval from Canadian and U.S. regulators to begin enrolling adults into the Phase 3 portion of its trials based on positive interim Phase 2 results. That portion of the trial is almost complete, with results expected to be available publicly in April.

In parallel with the Phase 3 trial, Medicago said it has also started a feasibility study of a vaccine candidate to address emerging variants of concern.

The Canadian company is also partnering with GlaxoSmithKline, which is testing its vaccine adjuvant technology. According to the U.K.-based GlaxoSmithKline, the use of an adjuvant may reduce the amount of vaccine protein required per dose.

“We are pleased to take the significant step of initiating the Phase 3 clinical trial at sites around the world,” said Takashi Nagao, CEO and president of Medicago. “This brings us one step closer to delivering an important new COVID-19 vaccine and contributing to the global fight against the pandemic along with our partner GSK.”

Phase 3 of Medicago’s vaccine trials will enrol up to 30,000 healthy adults between the ages of 18 and 65, followed by adults over the age of 65 and adults with comorbidities. The trial will take place across 10 countries, starting with Canada and the U.S., and seeks to enrol men and women from racially diverse populations.

Ottawa has signed a deal with Medicago to secure the rights to buy 76 million doses of its vaccine. The federal government has also pledged $173 million for the company’s vaccine research and development and for the construction of its Quebec City manufacturing facility.

According to federal government data, just over five per cent of Canadians have received their first dose of a COVID-19 vaccine as of March 6.

READ MORE: Canadian company reports promising early Phase 1 test results of possible COVID-19 vaccine

READ MORE: Public Health Agency of Canada budgets $5B for COVID-19 vaccines, treatments


@katslepian

katya.slepian@bpdigital.ca

Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

File Photo
Nominations for Sylvan Lake municipal election now open

Those looking to run for mayor or council can fill out and submit nomination forms now

People line up outside an immunization clinic to get their Oxford-AstraZeneca COVID-19 vaccine in Edmonton, Tuesday, April 20, 2021. THE CANADIAN PRESS/Jason Franson
Alberta passes bill to give all workers paid leave to get COVID-19 vaccine shot

Labour Minister Jason Copping says Bill 71 will reduce barriers for Alberta workers to get vaccinated

Alberta completed 18,412 COVID-19 tests, as reported on Wednesday, for a test positivity rate of 9.5 per cent. (NIAID-RML via AP)
Highest daily count of 2021 so far: Alberta reports 1,699 COVID-19 cases

Variants now make up 59 per cent of Alberta’s active cases

Alberta’s chief medical officer of health Dr. Deena Hinshaw and Premier Jason Kenney say the province would look at adding additional COVID-19 measures in the coming weeks if the virus continues to spread. (Photo by Government of Alberta)
Walk-in COVID-19 vaccination clinic to open in Red Deer

Alberta adds 1,345 new cases of the virus

(File photo)
Sylvan Lake RCMP investigate graffiti at local school

The graffiti was racially and culturally insensitive, RCMP say

Canadian Prime Minister Justin Trudeau and United States President Joe Biden smile as they say farewell following a virtual joint statement in Ottawa, Tuesday, February 23, 2021. THE CANADIAN PRESS/Adrian Wyld
Trudeau pledges to cut emissions by 40% to 45% by 2030, short of U.S. goal

Trudeau announced target during a virtual climate summit convened by U.S. President Joe Biden

Education Minister Adriana LaGrange was in Red Deer on Friday to provide an update on the province's COVID-19 response in schools.
Photo by PAUL COWLEY/Advocate staff
Alberta government aiming to boost financial literacy among students

Government providing grants to organizations who will help design financial literacy programming

President Joe Biden holds a virtual bilateral meeting with Canadian Prime Minister Justin Trudeau. (AP Photo/Evan Vucci)
U.S. to help Canada with more COVID-19 vaccine supply, Biden says

The U.S. has already provided Canada with about 1.5 million doses of the AstraZeneca vaccine

In this image from video, former Minneapolis police Officer Derek Chauvin, center, is taken into custody as his attorney, Eric Nelson, left, looks on, after the verdicts were read at Chauvin’s trial for the 2020 death of George Floyd, Tuesday, April 20, 2021, at the Hennepin County Courthouse in Minneapolis, Minn. THE CANADIAN PRESS/Court TV via AP, Pool
George Floyd’s death was ‘wake-up call’ about systemic racism: Trudeau

Derek Chauvin was found guilty Tuesday on all three charges against him

sign
Alberta Biobord Corp. recently hosted a virtual open house from Stettler

The company plans to develop a fuel pellet and medium density fibre board (MDF) plant near the community

The Rogers logo is photographed in Toronto on Monday, September 30, 2019. THE CANADIAN PRESS/Tijana Martin
Rogers investigating after wireless customers complain of widespread outage

According to Down Detector, problems are being reported in most major Canadian cities

People are shown at a COVID-19 vaccination site in Montreal, Sunday, April 18, 2021, as the COVID-19 pandemic continues in Canada and around the world. THE CANADIAN PRESS/Graham Hughes
Nothing stopping provinces from offering AstraZeneca vaccine to all adults: Hajdu

Health Canada has licensed the AstraZeneca shot for use in people over the age of 18

Most Read